[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_4481 

# __Rapidly developing drugs and vaccines for covid-19 by utilization of robots and cps technologies__

## Articles mentionning the risk

* [Arpaci_leveraging_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_397.md)

## Mitigations of this risk

* [Thorough testing and evaluation processes, strict regulatory oversight, and collaboration with medical experts.](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_6355.md)

## Name of the risk

Potential risks of incomplete testing and evaluation, leading to unforeseen side effects or ineffectiveness.

## People affected by this risk

* [Healthcare workers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_68.md)
* [Patients](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_31.md)

## Stakeholders who can mitigate this risk

* [Medical regulatory bodies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_124.md)
* [Pharmaceutical companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_3752.md)

## Technologies linked to the risk

* [Cps technologies](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_2290.md)
* [Robots](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_5436.md)

## This Risk belongs to this RiskGroup

* [Technological risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_8.md)

## This Risk belongs to this RiskSubgroup

* [Healthcare and medical risks](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_15.md)

